Lunchtime series webinar for the UK Therapeutic Cancer Prevention Network (UKTCPN) group
Dr Reading is open to collaboration with those who may have an interest in immune dynamics, surveillance and vaccine efficacy. Dr Reading & his team run deep antigen specific profiling on PBMC and tissue and have prototype biomarkers for lung, RCC & HCC (with the possibility to look into any solid cancer) and would be interested in interacting with anyone who has clinical samples especially those from preinvasive or invasive tissue in London.
Join via Teams: Join the meeting now